Published in Curr Opin Clin Nutr Metab Care on May 01, 2012
Cellular and molecular mechanisms of muscle atrophy. Dis Model Mech (2013) 2.40
Protein breakdown in muscle wasting: role of autophagy-lysosome and ubiquitin-proteasome. Int J Biochem Cell Biol (2013) 1.73
Skeletal muscle atrophy and the E3 ubiquitin ligases MuRF1 and MAFbx/atrogin-1. Am J Physiol Endocrinol Metab (2014) 1.55
Mechanisms for fiber-type specificity of skeletal muscle atrophy. Curr Opin Clin Nutr Metab Care (2013) 1.27
TRAF molecules in cell signaling and in human diseases. J Mol Signal (2013) 1.22
Context-Dependent Regulation of Autophagy by IKK-NF-κB Signaling: Impact on the Aging Process. Int J Cell Biol (2012) 0.87
Clinical classification of cancer cachexia: phenotypic correlates in human skeletal muscle. PLoS One (2014) 0.87
TWEAK/Fn14 pathway is a novel mediator of retinal neovascularization. Invest Ophthalmol Vis Sci (2014) 0.86
The TWEAK-Fn14 pathway: a potent regulator of skeletal muscle biology in health and disease. Cytokine Growth Factor Rev (2013) 0.85
Role of E2-Ub-conjugating enzymes during skeletal muscle atrophy. Front Physiol (2015) 0.85
PGC1α plays a critical role in TWEAK-induced cardiac dysfunction. PLoS One (2013) 0.85
Expression of TRAF6 and ubiquitin mRNA in skeletal muscle of gastric cancer patients. J Exp Clin Cancer Res (2012) 0.85
TWEAK promotes exercise intolerance by decreasing skeletal muscle oxidative phosphorylation capacity. Skelet Muscle (2013) 0.84
Translational studies in older men using testosterone to treat sarcopenia. Trans Am Clin Climatol Assoc (2014) 0.83
Muscle inflammation susceptibility: a prognostic index of recovery potential after hip arthroplasty? Am J Physiol Endocrinol Metab (2015) 0.80
Novel TAZ modulators enhance myogenic differentiation and muscle regeneration. Br J Pharmacol (2014) 0.79
Gene expression changes controlling distinct adaptations in the heart and skeletal muscle of a hibernating mammal. Physiol Genomics (2015) 0.78
New roles for Smad signaling and phosphatidic acid in the regulation of skeletal muscle mass. F1000Prime Rep (2014) 0.77
Molecular pathways leading to loss of skeletal muscle mass in cancer cachexia - can findings from animal models be translated to humans? BMC Cancer (2016) 0.77
Muscle RANK is a key regulator of Ca2+ storage, SERCA activity, and function of fast-twitch skeletal muscles. Am J Physiol Cell Physiol (2016) 0.76
Absence of 4-1BB reduces obesity-induced atrophic response in skeletal muscle. J Inflamm (Lond) (2017) 0.75
Systematic protein-protein interaction and pathway analyses in the idiopathic inflammatory myopathies. Arthritis Res Ther (2016) 0.75
MicroRNA-351 inhibits denervation-induced muscle atrophy by targeting TRAF6. Exp Ther Med (2016) 0.75
The impact of post exercise essential amino acid ingestion on the ubiquitin proteasome and autophagosomal-lysosomal systems in skeletal muscle of older men. J Appl Physiol (1985) (2016) 0.75
BGP-15 Protects against Oxaliplatin-Induced Skeletal Myopathy and Mitochondrial Reactive Oxygen Species Production in Mice. Front Pharmacol (2017) 0.75
Expression of tumor necrosis factor-like weak inducer of apoptosis and fibroblast growth factor-inducible 14 in patients with polymyositis and dermatomyositis. Arthritis Res Ther (2014) 0.75
It's all about talking: two-way communication between proteasomal and lysosomal degradation pathways via ubiquitin. Am J Physiol Cell Physiol (2016) 0.75
Disrupted Skeletal Muscle Mitochondrial Dynamics, Mitophagy, and Biogenesis during Cancer Cachexia: A Role for Inflammation. Oxid Med Cell Longev (2017) 0.75
TAK1 is a ubiquitin-dependent kinase of MKK and IKK. Nature (2001) 11.84
Proteasome-independent functions of ubiquitin in endocytosis and signaling. Science (2007) 6.65
The E3 ligase TRAF6 regulates Akt ubiquitination and activation. Science (2009) 4.63
TLR activation of the transcription factor XBP1 regulates innate immune responses in macrophages. Nat Immunol (2010) 4.56
Autophagy is required to maintain muscle mass. Cell Metab (2009) 4.46
Distinct molecular mechanism for initiating TRAF6 signalling. Nature (2002) 3.82
Signaling in muscle atrophy and hypertrophy. Physiology (Bethesda) (2008) 3.68
Site-specific Lys-63-linked tumor necrosis factor receptor-associated factor 6 auto-ubiquitination is a critical determinant of I kappa B kinase activation. J Biol Chem (2006) 3.51
Signal integration and diversification through the p62 scaffold protein. Trends Biochem Sci (2006) 3.50
The TWEAK-Fn14 cytokine-receptor axis: discovery, biology and therapeutic targeting. Nat Rev Drug Discov (2008) 3.25
TRAF6 and A20 regulate lysine 63-linked ubiquitination of Beclin-1 to control TLR4-induced autophagy. Sci Signal (2010) 3.23
The novel functions of ubiquitination in signaling. Curr Opin Cell Biol (2004) 2.93
The E3 Ligase MuRF1 degrades myosin heavy chain protein in dexamethasone-treated skeletal muscle. Cell Metab (2007) 2.84
Targeted ablation of TRAF6 inhibits skeletal muscle wasting in mice. J Cell Biol (2010) 2.47
Osteoclast differentiation independent of the TRANCE-RANK-TRAF6 axis. J Exp Med (2005) 2.21
Autophagy in skeletal muscle. FEBS Lett (2010) 2.13
TWEAK-FN14 signaling induces lysosomal degradation of a cIAP1-TRAF2 complex to sensitize tumor cells to TNFalpha. J Cell Biol (2008) 2.11
Nuclear factor-kappa B signaling in skeletal muscle atrophy. J Mol Med (Berl) (2008) 1.86
Signaling pathways perturbing muscle mass. Curr Opin Clin Nutr Metab Care (2010) 1.79
TWEAK, via its receptor Fn14, is a novel regulator of mesenchymal progenitor cells and skeletal muscle regeneration. EMBO J (2006) 1.73
TWEAK/Fn14 pathway: an immunological switch for shaping tissue responses. Immunol Rev (2011) 1.70
The TWEAK-Fn14 system is a critical regulator of denervation-induced skeletal muscle atrophy in mice. J Cell Biol (2010) 1.61
TNF-related weak inducer of apoptosis (TWEAK) is a potent skeletal muscle-wasting cytokine. FASEB J (2007) 1.60
Tumor necrosis factor-like weak inducer of apoptosis inhibits skeletal myogenesis through sustained activation of nuclear factor-kappaB and degradation of MyoD protein. J Biol Chem (2006) 1.55
The role of cytokines in cancer cachexia. Curr Opin Support Palliat Care (2009) 1.52
NF-kappaB signaling: a tale of two pathways in skeletal myogenesis. Physiol Rev (2010) 1.41
TRAF6 ubiquitin ligase is essential for RANKL signaling and osteoclast differentiation. Biochem Biophys Res Commun (2007) 1.30
The transcription factor ATF4 promotes skeletal myofiber atrophy during fasting. Mol Endocrinol (2010) 1.23
Regulation of TNFRSF and innate immune signalling complexes by TRAFs and cIAPs. Cell Death Differ (2010) 1.20
Identification of genes that elicit disuse muscle atrophy via the transcription factors p50 and Bcl-3. PLoS One (2011) 1.17
TNF-like weak inducer of apoptosis (TWEAK) activates proinflammatory signaling pathways and gene expression through the activation of TGF-beta-activated kinase 1. J Immunol (2009) 1.14
Genetic ablation of TWEAK augments regeneration and post-injury growth of skeletal muscle in mice. Am J Pathol (2010) 1.13
The E3 ubiquitin ligase TRAF6 intercedes in starvation-induced skeletal muscle atrophy through multiple mechanisms. Mol Cell Biol (2012) 1.10
Molecular basis for the unique specificity of TRAF6. Adv Exp Med Biol (2007) 1.06
The JNK MAP kinase pathway contributes to the development of endotoxin-induced diaphragm caspase activation. Am J Physiol Regul Integr Comp Physiol (2009) 1.04
NF-κB signaling in skeletal muscle health and disease. Curr Top Dev Biol (2011) 1.02
TWEAK causes myotube atrophy through coordinated activation of ubiquitin-proteasome system, autophagy, and caspases. J Cell Physiol (2012) 1.01
The TWEAK-Fn14 system: breaking the silence of cytokine-induced skeletal muscle wasting. Curr Mol Med (2012) 0.96
No end in site: TWEAK/Fn14 activation and autoimmunity associated- end-organ pathologies. J Leukoc Biol (2008) 0.95
Targeting TRAfs for therapeutic intervention. Adv Exp Med Biol (2007) 0.95
Adiponectin inhibits induction of TNF-alpha/RANKL-stimulated NFATc1 via the AMPK signaling. FEBS Lett (2008) 0.94
TRAF6 regulates proliferation and differentiation of skeletal myoblasts. Differentiation (2010) 0.86
Targeted ablation of TRAF6 inhibits skeletal muscle wasting in mice. J Cell Biol (2010) 2.47
The TWEAK-Fn14 system is a critical regulator of denervation-induced skeletal muscle atrophy in mice. J Cell Biol (2010) 1.61
Resveratrol and estradiol rapidly activate MAPK signaling through estrogen receptors alpha and beta in endothelial cells. J Biol Chem (2004) 1.59
Matrix metalloproteinase-9 inhibition ameliorates pathogenesis and improves skeletal muscle regeneration in muscular dystrophy. Hum Mol Genet (2009) 1.44
Genomic profiling of messenger RNAs and microRNAs reveals potential mechanisms of TWEAK-induced skeletal muscle wasting in mice. PLoS One (2010) 1.22
Genetic ablation of TWEAK augments regeneration and post-injury growth of skeletal muscle in mice. Am J Pathol (2010) 1.13
The E3 ubiquitin ligase TRAF6 intercedes in starvation-induced skeletal muscle atrophy through multiple mechanisms. Mol Cell Biol (2012) 1.10
Matrix metalloproteinase inhibitor batimastat alleviates pathology and improves skeletal muscle function in dystrophin-deficient mdx mice. Am J Pathol (2010) 1.02
Osteopontin-stimulated expression of matrix metalloproteinase-9 causes cardiomyopathy in the mdx model of Duchenne muscular dystrophy. J Immunol (2011) 0.98
Elevated levels of active matrix metalloproteinase-9 cause hypertrophy in skeletal muscle of normal and dystrophin-deficient mdx mice. Hum Mol Genet (2011) 0.96
Regulatory circuitry of TWEAK-Fn14 system and PGC-1α in skeletal muscle atrophy program. FASEB J (2013) 0.96
Reciprocal interaction between TRAF6 and notch signaling regulates adult myofiber regeneration upon injury. Mol Cell Biol (2012) 0.89
TWEAK promotes exercise intolerance by decreasing skeletal muscle oxidative phosphorylation capacity. Skelet Muscle (2013) 0.84